Pharmacokinetic-Moedeling
Showing 1 - 25 of 6,082
TB Drugs and Bacterial Drug Resistance
Completed
- Tuberculosis
- Non-Tuberculosis Mycobacteria
-
Bethesda, Maryland
- +1 more
Mar 25, 2022
Healthy Subjects Trial in Shanghai (JYP0061, )
Completed
- Healthy Subjects
- JYP0061
- placebo
-
Shanghai, Shanghai, ChinaShanghai Xuhui District Central Hospital
Nov 16, 2023
Based on Quantitative Pharmacology in Patients With Lenalidomide
Recruiting
- Multiple Myeloma
- +2 more
-
Jinan, Shandong, Chinathe First Affiliated Hospital of Shandong First Medical Universi
Oct 3, 2023
Carbapenem Resistant Klebsiella Pneumoniae Trial in Ratchathewi (Dose-adjustment by PKPD)
Recruiting
- Carbapenem Resistant Klebsiella Pneumoniae
- Dose-adjustment by PKPD
-
Ratchathewi, Bangkok, ThailandPhramongkutklao Hospital
May 7, 2023
Infertility Trial in Chengdu, (GenSci094)
Recruiting
- Infertility
-
Chengdu,, Sichuan, ChinaChengdu Xinhua Hospital, affiliated with Sichuan North Medical C
Oct 18, 2023
Based on Quantitative Pharmacology in Patients With Pamipril
Not yet recruiting
- Ovarian Cancer
- (no location specified)
Apr 28, 2023
Myelofibrosis Trial in Changsha (Jaktinib Hydrochloride Tablets)
Not yet recruiting
- Myelofibrosis
- Jaktinib Hydrochloride Tablets
-
Changsha, Hunan, ChinaThe Third Hospital of Changsha
Nov 9, 2023
Asthma Trial in Beijing (GR2002 injection, Placebo)
Recruiting
- Asthma
- GR2002 injection
- Placebo
-
Beijing, ChinaPeking University People's Hospital
Jul 13, 2023
Hypertension Trial (CKD-828, D064, D701)
Not yet recruiting
- Hypertension
- CKD-828, D064, D701
- (no location specified)
Apr 18, 2023
Hypertension Trial (CKD-828, D064, D702)
Not yet recruiting
- Hypertension
- CKD-828, D064, D702
- (no location specified)
May 21, 2023
Type 2 Diabetes Trial in Beijing (HSK7653 10 mg, HSK7653 25 mg, HSK7653 50 mg)
Completed
- Type 2 Diabetes Mellitus
- HSK7653 10 mg
- +3 more
-
Beijing, Beijing, ChinaPeking university people's hospital
Sep 23, 2023
Gastro Esophageal Reflux Trial (Lansoprazole 15 mg, Lansoprazole 15mg/Calcium carbonate 600mg)
Not yet recruiting
- Gastro Esophageal Reflux
- Lansoprazole 15 mg
- Lansoprazole 15mg/Calcium carbonate 600mg
- (no location specified)
Sep 3, 2023
Severe Hemophilia A Without Inhibitor, Joint Bleed Trial in Bangkok ("Emicizumab", "HEMLIBRA®")
Recruiting
- Severe Hemophilia A Without Inhibitor
- Joint Bleed
- "Emicizumab", "HEMLIBRA®"
-
Bangkok, ThailandKing Chulalongkorn Memorial hospital
Nov 25, 2023
Hypertension, Diabetes, Type 2 Trial in Seoul (THP-00101 (Dapagliflozin) 10mg, THP-00102 (Telmisartan) 80mg)
Recruiting
- Hypertension
- Diabetes Mellitus, Type 2
- THP-00101 (Dapagliflozin) 10mg
- THP-00102 (Telmisartan) 80mg
-
Seoul, Korea, Republic ofH Plus Yangji Hospital
Sep 25, 2023
Type 2 Diabetes Trial (Acetaminophen/SHR20004, Acetaminophen/Placebo)
Not yet recruiting
- Type 2 Diabetes Mellitus
- Acetaminophen/SHR20004
- Acetaminophen/Placebo
- (no location specified)
Nov 17, 2023
Diabetes type2 Trial in Seoul (D745, D759, D150)
Not yet recruiting
- Diabetes type2
- D745, D759, D150
-
Seoul, Korea, Republic ofCatholic Hospital, Seoul
Jun 26, 2023
Healthy Trial in Wuhan (Tegoprazan, Bismuth, Amoxicilli)
Completed
- Healthy
- Tegoprazan
- +3 more
-
Wuhan, Hubei, ChinaUnion Hospital, Tongji Medical College, Huazhong University of S
Jun 22, 2023
Eye Diseases, Presbyopia, Refractive Errors Trial in Newport Beach (Aceclidine + Brimonidine, Aceclidine)
Recruiting
- Eye Diseases
- +5 more
- Aceclidine + Brimonidine
- Aceclidine
-
Newport Beach, CaliforniaSite #101
Jul 7, 2023
MDS Trial in Hangzhou (IV Decitabine, Decitabine and cedazuridine, only Decitabine and cedazuridine)
Recruiting
- Myelodysplastic Syndromes
- IV Decitabine
- +2 more
-
Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital,Zhejiang University School of Medi
Oct 23, 2023
Peripheral Artery Disease Trial in Perth (BRight DCB)
Not yet recruiting
- Peripheral Artery Disease
- BRight DCB
-
Perth, WAUS, AustraliaRoyal Perth Hospital
Oct 2, 2023
Serous Ovarian Cancer, Advanced Ovarian Cancer Trial (SC0191, Gemcitabine, Paclitaxel)
Not yet recruiting
- Serous Ovarian Cancer
- Advanced Ovarian Cancer
- SC0191
- +2 more
- (no location specified)
Sep 20, 2023
Pharmacokinetics Trial (WCK 2349 Oral, Placebo Oral)
Completed
- Pharmacokinetics
- WCK 2349 Oral
- Placebo Oral
- (no location specified)
Nov 28, 2022
Primary Immunodeficiency Disease Trial (Boya IVIG)
Not yet recruiting
- Primary Immunodeficiency Disease
- Boya IVIG
- (no location specified)
Nov 21, 2023
HIV-1 Trial in Beijing (1 mg CL-197 capsules or CL-197 , 10 mg CL-197 capsules or CL-197 , 30 mg CL-197 capsules or CL-197 )
Recruiting
- HIV-1
- 1 mg CL-197 capsules or CL-197 placebo
- +4 more
-
Beijing, Beijing, ChinaThe Fifth Medical Center of Chinese PLA General Hospital
Jul 12, 2023